These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

108 related articles for article (PubMed ID: 9232540)

  • 41. Effects on non-depolarizing neuromuscular blocking agents on peripheral autonomic mechanisms in cats.
    Hughes R; Chapple DJ
    Br J Anaesth; 1976 Feb; 48(2):59-68. PubMed ID: 130154
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Thermal injury induces greater resistance to d-tubocurarine in local rather than in distant muscles in the rat.
    Ibebunjo C; Martyn JA
    Anesth Analg; 2000 Nov; 91(5):1243-9. PubMed ID: 11049916
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Non-depolarizing neuromuscular blocking activity of bisquaternary amino di- and tripeptide derivatives.
    Booij LH; van der Broek LA; Caulfield W; Dommerholt-Caris BM; Clark JK; van Egmond J; McGuire R; Muir AW; Ottenheijm HC; Rees DC
    J Med Chem; 2000 Dec; 43(25):4822-33. PubMed ID: 11123992
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Rate of onset and offset of neuromuscular block in the isolated rat diaphragm.
    Brookes N; Mackay D
    Br J Pharmacol; 1971 Feb; 41(2):339-43. PubMed ID: 4252231
    [No Abstract]   [Full Text] [Related]  

  • 45. Curare-like agents: relation between lipid solubility and transport into bile in perfused rat liver.
    Meijer DK; Weitering JG
    Eur J Pharmacol; 1970 May; 10(2):283-9. PubMed ID: 4245935
    [No Abstract]   [Full Text] [Related]  

  • 46. The neuromuscular blocking effect of trimetaphan alone and in combination with different non-depolarizing muscle relaxants in the rat.
    Pollard BJ; van der Spek AF
    J Pharm Pharmacol; 1987 Nov; 39(11):896-9. PubMed ID: 2892913
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Inhibition of the enzymic degradation of suxamethonium and mivacurium increases the onset time of submaximal neuromuscular block.
    Beaufort TM; Nigrovic V; Proost JH; Houwertjes MC; Wierda JM
    Anesthesiology; 1998 Sep; 89(3):707-14. PubMed ID: 9743409
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Pharmacodynamics and pharmacokinetics of metocurine in humans: comparison to d-tubocurarine.
    Matteo RS; Brotherton WP; Nishitateno K; Khambatta HJ; Dias J
    Anesthesiology; 1982 Sep; 57(3):183-90. PubMed ID: 6287887
    [No Abstract]   [Full Text] [Related]  

  • 49. Chemical structure and pharmacological (curarizing) properties of various indole alkaloids extracted from an African Strychnos.
    Angenot L; Dubois M; Ginion C; van Dorsser W; Dresse A
    Arch Int Pharmacodyn Ther; 1975 Jun; 215(2):246-58. PubMed ID: 126050
    [TBL] [Abstract][Full Text] [Related]  

  • 50. The effects of diethyl ether, enflurane, and isoflurane at the neuromuscular junction.
    Waud BE; Waud DR
    Anesthesiology; 1975 Mar; 42(3):275-80. PubMed ID: 124148
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Neuromuscular blocking properties of some bistropinium esters.
    HAINING CG; JOHNSTON RG
    Br J Pharmacol Chemother; 1962 Apr; 18(2):275-86. PubMed ID: 13903721
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Neuromuscular block.
    Bowman WC
    Br J Pharmacol; 2006 Jan; 147 Suppl 1(Suppl 1):S277-86. PubMed ID: 16402115
    [TBL] [Abstract][Full Text] [Related]  

  • 53. The importance of myorelaxants in anesthesia.
    Flood P
    Curr Opin Pharmacol; 2005 Jun; 5(3):322-7. PubMed ID: 15907920
    [TBL] [Abstract][Full Text] [Related]  

  • 54. [A case of prolonged neuromuscular blockade possibly related to a high anti-acetylcholine receptor antibody level].
    Kido K; Uchida T; Makita K
    Masui; 2013 Apr; 62(4):445-8. PubMed ID: 23697199
    [TBL] [Abstract][Full Text] [Related]  

  • 55. The development of ultrashort acting neuromuscular relaxant tropane derivatives.
    Gyermek L; Lee C
    J Crit Care; 2009 Mar; 24(1):58-65. PubMed ID: 19272540
    [TBL] [Abstract][Full Text] [Related]  

  • 56. [An overview of the pharmacokinetics and pharmacodynamics of rocuronium bromide].
    Iwasaki H
    Masui; 2006 Jul; 55(7):826-33. PubMed ID: 16856542
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Neuromuscular blocking activity of aminoglycoside antibiotics.
    Paradelis AG; Triantaphyllidis C; Giala MM
    Methods Find Exp Clin Pharmacol; 1980 Feb; 2(1):45-51. PubMed ID: 6121961
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Comparative clinical pharmacokinetics of tubocurarine, gallamine, alcuronium and pancuronium.
    Buzello W; Agoston S
    Anaesthesist; 1978 Jul; 27(7):313-8. PubMed ID: 150804
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Enzymatic hydrolysis of atracurium in vivo.
    Nigrovic V; Auen M; Wajskol A
    Anesthesiology; 1985 May; 62(5):606-9. PubMed ID: 3838864
    [TBL] [Abstract][Full Text] [Related]  

  • 60. The interactions of hexafluorenium with depolarizing and competitive neuromuscular blocking agents.
    Scaf AH; van den Akker J; Berends F
    Arch Int Pharmacodyn Ther; 1974 Mar; 208(1):166-76. PubMed ID: 4276930
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.